Speed Networking and Networking Breakfast Mentor Guide

Transcription

Speed Networking and
Networking Breakfast
Mentor Guide
Co-Sponsored by:
ASBMR Women in Bone and Mineral Research and
Membership Engagement and Education Committees
Speed Networking Event, Friday, September 12, 8:00 p.m. - 10:00 p.m.,
Ballroom of the Americas A/Hilton Americas, Reception to Follow
Networking Breakfast, Saturday, September 13, 6:45 a.m. - 8:00 a.m., Grand
Ballroom A/George R. Brown Convention Center, Breakfast Provided
ASBMR 2014 Annual Meeting / Houston, Texas, USA / September 12-15, 2014
Cheryl Ackert-Bicknell, Ph.D.
University of Rochester
E-Mail: [email protected]
Attending: Speed Networking
Event and Networking Breakfast
Matthew Allen, Ph.D.
Indiana University School of
Medicine
Attending: Networking Breakfast
Dr. Ackert-Bicknell is an Associate
Professor in the Center for Musculoskeletal Research at the University of Rochester in Rochester,
New York, USA. The focus of her research program is
the study of the genetic regulation of bone mass. She
examines the genetic relationship between low bone
mass and serum cholesterol and serum HDL. She also
works with the GEFOS Consortium to conduct functional validation of loci for bone phenotypes as identified by GWAS. Lastly, she is part of a multiinstitutional team conducting in depth bone phenotyping of mice generated as part of the Knockout
Mouse Project (KOMP).
Dr. Allen’s laboratory studies the
tissue-level mechanisms responsible for skeletal integrity in health and disease. They
utilize numerous in vivo model systems to understand how disease and pharmaceutical interventions
influence bone structure, cellular activity, tissue-level
properties (mineralization, microdamage, collagen,
hydration), and biomechanical properties. They study
diseases/conditions including osteoporosis, chronic
kidney disease, osteogenesis imperfecta, and disuse,
using techniques such as imaging (CT, DXA, X-ray),
histology (static and dynamic histomorphometry, microdamage), and mechanical testing (bending, compression, reference point indentation). The laboratory is funded by the National Institutes of Health,
NASA/NSBRI, IU School of Medicine, and industry.
More information can be found at the laboratory
website here.
John Adams, M.D.
University of California,
Los Angeles
E-Mail:
[email protected]
Tamara Alliston, Ph.D.
San Francisco
E-Mail:
[email protected]
and Speed Networking Event
Dr. Adams is Professor and Vice
Chair for Research in the UCLA
Department of Orthopaedic Surgery in the David Geffen School of Medicine. He is co-appointed as Professor in the Department of Molecular, Cell and Developmental Biology in the UCLA College of Arts and
Letters. He serves as the Associate Director of the
NIH-funded Clinical and Translational Science Institute and Assistant Dean for Translational Research at
UCLA. His bench-to-bedside, translational research
efforts in the area of Vitamin D have been continuously funded by the NIH for the last 34 years. He is a
past member of the ASBMR Council and Associate
Editor of the JBMR®.
Dr. Alliston is an Associate Professor within the UCSF
Department of Orthopaedic Surgery. With a focus on
TGFβ signaling, her laboratory investigates the interaction between physical and biochemical signals in
the control of skeletal cell differentiation and the role
of these pathways in skeletal development and disease. Dr. Alliston’s lab combines tools and approaches from molecular biology as well as from materials
science and engineering. By investigating the basic
cellular mechanisms controlling osteoblast and chondrocyte behavior, her group strives to elucidate
mechanisms of skeletal diseases and improve the design of strategies to prevent or treat them.
A
—
A
Alicia Bagur, M.D., Ph.D.
Mautalen Salud e
Investigacion
E-Mail:
[email protected]
Attending: Networking
Breakfast
Rob Blank, M.D., Ph.D.
Medical College of Wisconsin
Dr. Blank is Professor of Medicine and Chief of the Division of
Endocrinology, Metabolism, and
Dr. Bagur is an
Clinical Nutrition at the Medical
endocrinologist and has
College of Wisconsin. He is currently Director of the
been working in Metabolic Bone Diseases since
TOPS Obesity Center and a trainer in the Interdiscipli1986. She has been an Associate Director in
Mautalen Health and Research since 2000. She has nary Program in Biomedical Sciences. Dr. Blank’s laserved as President of the Argentine Association of boratory studies the genetics of bone biomechanical
performance and of vertebral development, primarily
Osteology and Mineral Metabolism (2000-2001)
and as Chief of the Metabolic Bone Unit, University in mice. The lab is particularly interested in understanding the relationship among different aspects of
Hospital of Buenos Aires, Argentina (2003-2010).
biomechanical performance and the mechanisms unDr. Bagur has been a Principal/Sub Investigator,
derlying pleiotropy of bone quantitative trait loci.
Trials of New Treatments for Osteoporosis since
The Blank lab is also interested in understanding the
1966.
genetic basis of congenital vertebral malformations
and idiopathic scoliosis.
Teresita Bellido, Ph.D.
Indiana University School of
Medicine
Attending: Speed Networking Event and Networking
Breakfast
Dr. Bellido is a Professor of
Anatomy and Cell Biology as
well as Adjunct Professor of
Medicine, Endocrinology at
the Indiana University School of Medicine. Her research focuses on signal transduction in bone cells,
with particular emphasis in the biology of osteocytes
and the mechanisms by which these cells control the
function of osteoblasts and osteoclasts. She currently
chairs the Bone Journal Club and co-chairs the Indiana Bone and Mineral Metabolism Club, lectures at
local, national, and international scientific meetings
and participates in the organization of scientific
meetings in the area of skeletal biology by serving on
advisory boards. Dr. Bellido is the Chair of the ASBMR Women in Bone and Mineral Research Committee.
Lynda Bonewald, Ph.D.
University of Missouri – Kansas
City School of Dentistry
Dr. Bonewald is the Vice Chancellor for Translational and Clinical Research, Curators’ Professor, Lee M. and William Lefkowitz Professor, Director,
UMKC-CEMT, and Director, Bone Biology Research
Program in the UMKC School of Dentistry, Department of Oral Biology. She performs research in the
area of bone and directs the Mineralized Tissue Biology. She is a member of the Association of Biomolecular Resource Facilities, the International Bone and
Mineral Society, the American Association for Dental
Research and the International Association for Dental
Research. Dr. Bonewald is an ASBMR Past-President.
B
—
B
Roger Bouillon, M.D., Ph.D., FRCP
University and University Hospital
of the Catholic University of Leuven
E-Mail:
[email protected]
Dr. Bouillon is a Professor of Endocrinology at the University Hospital
of the Catholic University of Leuven in Belgium. His research deals with various aspects of bone and calcium homeostasis and spans the
spectrum of basic, translational and clinical research.
Dr. Bouillon has held the following positions: member
of the Royal Academy of Medicine, founding member
and later President of the European Board of Endocrinology, Board member of the European Medical Research Council, immediate past-president of the International Bone and Mineral Society, co-organizer of
the vitamin D workshop, and Vice President for research at the University of Leuven.
Brendan Boyce, M.D.
University of Rochester
Medical Center
Dr. Boyce started his career as a pathologist in Scotland examining bone biopsy specimens from patients
with common bone diseases using histomorphometry. He learned experimental cell and molecular biology techniques during a 2-year sabbatical in Greg
Mundy’s lab in Texas. Dr. Boyce returned to San Antonio in 1990 and collaborated with Greg and his
group extending the use of animal models of bone
diseases before moving to Rochester, NY in 1999. His
lab studies the role of NF-kB signaling in stem cells
and osteoclast and osteoblast functions. He sees a
wide spectrum of diseases affecting humans and especially those affecting the skeleton. Dr. Boyce is a
past ASBMR Secretary-Treasurer.
Jane Cauley, DrPH
University of Pittsburgh
Graduate School of
Public Health
Attending: Speed Networking Event
Dr. Cauley is Professor and Vice Chair for Research in
the Department of Epidemiology and her primary research interest is the epidemiology of osteoporosis,
osteoporosis treatment, and the consequences of
osteoporosis in both men and women. She also has a
major interest in menopause and the multiple physiological, social, pathological changes that occur during
this time. Dr. Cauley was Co-PI for the Women's
Health Initiative and served as study wide Chair of the
Osteoporosis, Calcium, and Vitamin D Committee for
almost the entire duration of the trial, and a Coinvestigator for the Study of Women's Health Across
the Nation.
Wenhan Chang, Ph.D.
VA Medical Center and University of
California, San Francisco
Dr. Chang is Professor of Medicine at University of
California San Francisco and the Director of the San
Francisco VA Medical Center Bone Imaging Core. His
basic and translational research utilizes genetically
manipulated mouse models, uCT imaging, histomorphometry, primary bone cell and chondrocyte cultures, single-cell imaging and molecular biology techniques to investigate the role of calcium, 1,25dihydroxyvitamin D3, IGF1 and their receptors (CaSR,
VDR, and IGF1R) in parathyroid cell functions, mineral
homeostasis, skeletal development and bone fracture
healing. He has been a member of ASBMR since 1992
and previously served as the Chair of the Membership Engagement Committee.
B
—
C
Di Chen, M.D., Ph.D.
Rush University Medical Center
Event
Dr. Chen is a Professor and
Chairman in the Department of
Biochemistry. His research interests include skeletal development and remodeling and molecular mechanisms of degenerative and genetic
bone diseases. Dr. Chen is a member of ASBMR,
IBMS, ORS, NYAS, ACR, OARSI and AACR and serves
on the editorial board for the JBMR®, Arthritis and
Rheumatism, Journal of Biological Chemistry, Journal
of Cellular Biochemistry, Arthritis Research and Therapy, Osteoarthritis and Cartilage, and Calcified Tissue
International. He previously served on the ASBMR
Education Committee and was a member of the ASBMR Working Group on Outreach to Bone Scientists
in China.
Sylvia Christakos, Ph.D.
New Jersey Medical School in
Newark, New Jersey
Bart Clarke, M.D.
Mayo Clinic College of Medicine and Mayo Clinic
E-Mail:
[email protected]
Attending: Networking Breakfast and Speed Networking
Event
Dr. Clarke is Consultant and
Chair of the Metabolic Bone
Disease Core Group in the Division of Endocrinology,
Diabetes, Metabolism, and Nutrition at the Mayo
Clinic, and Associate Professor of Medicine in the
Mayo Clinic College of Medicine. He completed his
residency in internal medicine and fellowship in endocrinology and metabolism at the Mayo Graduate
School of Medicine and he completed further fellowship training in bone and mineral metabolism at the
Mayo Clinic. His main clinical research interests include postmenopausal osteoporosis, new anabolic
therapies, glucocorticoid- and transplantationinduced osteoporosis, tumor-induced osteomalacia,
primary hyperparathyroidism, and hypoparathyroidism. Dr. Clarke is an ASBMR Councilor.
Thomas Clemens, Ph.D.
Johns Hopkins University
Dr. Christakos is a professor of
Dr. Clemens is Professor in the
Biochemistry at New Jersey MedDepartment of Orthopaedic Surical School. Her main area of
gery and the Director of the Ceninterest is in vitamin D, particularly vitamin D functer for Musculoskeletal Research at Johns Hopkins
tion and transcriptonal regulation. Dr. Christakos is University. His research is focused on identification of
an ASBMR Past President.
the cellular and molecular mechanismswhich control
bone osteoblast activity. Dr. Clemens founded a Masters program in Biomedical Sciences at Cedars Sinai
Medical Center, directed the Pathobiology and Molecular Medicine graduate program at the University
of Cincinnati and established a Med to Grad doctoral
program at the University of Alabama. He served on
the ASBMR Council, was the program co-chair for the
ASBMR 2002 Annual Meeting, and is the immediate
past Editor-in-Chief of the JBMR®.
C
—
C
Jillian Cornish, Ph.D.
University of Auckland,
New Zealand and University of
Oxford
Robin Daly, Ph.D.
Centre for Physical Activity and
Nutrition Research,
Deakin University
Dr. Cornish leads the Cell and
Molecular Bone/Joint Biology
Research Group in Department
of Medicine, University of Auckland, New Zealand. Dr Cornish’s group investigates
peptides and lipids that are anabolic to bone cells,
cartilage and tendon cells for which they hold international patents. The group has established numerous in vitro and in vivo models in skeletal biology and
developed a keen interest in skeletal regenerative
medicine. Dr. Cornish is on the boards of the International Bone and Mineral Society, International Bone
Morphometry Society and is a Past-President of Australian and New Zealand Bone and Mineral Society.
*Dr. Cornish is the 2014 ASBMR Paula Stern Achievement Awardee
Dr. Daly holds the position of
Chair in Exercise and Ageing and is the co-leader of
the Clinical and Biomedical Research program within
the Centre for Physical Activity and Nutrition Research at Deakin University in Melbourne, Australia.
His research is focused on conducting clinical and
translational randomised controlled trials to evaluate
the independent and combined effects of exercise
and nutrition for the prevention of common chronic
diseases such as osteoporosis, sarcopenia, falls and
type 2 diabetes; health issues related to vitamin D
deficiency, dietary protein and chronic low-grade systemic inflammation, and the translation of evidencebased research into practice.
Carolyn Crandall, M.D., M.S.
Los Angeles
E-Mail:
[email protected]
Breakfast
Janine Danks, BSc, MSc, Ph.D.,
FFSC (RCPA)
School of Medical Sciences,
RMIT University
E-Mail:
[email protected]
Attending: No longer attending
Dr. Crandall's research is focused on osteoporosis
Dr. Danks’ research interest is
screening strategies in postmenopausal women, the
the presence and functions of
epidemiology of postmenopausal osteoporosis, and
calcium regulating hormones,
the influence of psychosocial stressors on osteoporo- particularly the parathyroid hormone family including
sis in adults.
parathyroid hormone-related protein (PTHrP) in lower vertebrates, culminating in 62 papers, 5 reviews
and 5 book chapters. She established the immunohistochemical method for the localization of PTHrP
that has been used extensively around the world. The
original paper was selected by the JBMR® in 2003 as
one of the 21 most important papers published by it
in the first 25 years. Her laboratory is currently using
comparative endocrinology and oncology to examine
the role of PTHrP in tumour biology.
C
—
D
Marie Demay, M.D.
Harvard Medical School
and Massachusetts General
Hospital
E-Mail:
[email protected]
Breakfast and Speed Networking Event
Dr. Demay is Professor of Medicine at Harvard Medical School and an Endocrinologist at the Massachusetts General Hospital. Her main research interests
are the molecular basis for the in vivo abnormalities
that result from impaired Vitamin D action, including the effect of phosphate on the maturing growth
plate. Her laboratory is funded by grants from the
National Institutes of Arthritis and Musculoskeletal
and Skins Disorders and the National Institute of Diabetes and Digestive and Kidney Diseases. Dr.
Demay has served on several ASBMR committees,
was a member of the ASBMR Council and the Advances in Mineral Metabolism Board of Directors,
served as a Program Co-chair for the ASBMR 2004
Annual Meeting and received the 2011 Paula Stern
Achievement Award.
Paola Divieti Pajevic, M.D., Ph.D.
Massachusetts General Hospital
and Harvard Medical School
E-Mail:
[email protected]
Event
Dr. Divieti Pajevic is an Associate
Professor of Medicine at Harvard
Medical School, and she is a member of the Endocrine Unit at Massachusetts General Hospital in Boston. Dr. Divieti Pajevic received her Medical Degree
from the University of Milan and her Ph.D. in Pathophysiology from the University of Florence, Italy. Her
laboratory is interested in investigating the effects of
hormones (Parathyroid hormone), intracellular signaling and mechanical forces (gravity) on osteocytes
both “in vivo”, using genetically modified animal
models, and “in vitro”. She is the principal investigator of several federally funded grants and the recipient of several prestigious awards.
Matthew Drake, M.D., Ph.D.
Mayo Clinic
E-Mail:
[email protected]
Breakfast
Dr. Drake is a Consultant in
Endocrinology and received
his AB degree from Harvard
and M.D./Ph.D. degrees from Washington University.
He trained in Internal Medicine at Duke University,
and Endocrinology at Mayo. He is board certified in
Internal Medicine and Endocrinology and his research
is primarily translational, with areas of interest including understanding the mechanisms underlying
age-associated bone loss, as well as the basis by
which monoclonal gammopathies induce bone loss
and fractures. In his clinical practice, Dr. Drake provides care to patients with a variety of metabolic
bone diseases. He currently serves on the ASBMR
Professional Practice Committee.
Gustavo Duque, M.D.,
Ph.D.
Ageing Bone Research Program, University of Sydney
E-Mail:
[email protected]
Breakfast
Dr. Duque is a faculty member at Sydney Medical
School Nepean as Professor of Geriatric Medicine and
Director of the Ageing Bone Research Centre. His major research interests include the elucidation of the
mechanisms of age-related bone loss. He is also looking at the effect of vitamin D on bone and muscle
mass. His work on mesenchymal stem cells differentiation has provided new evidence to the understanding of senile osteoporosis including the toxic role of
bone marrow fat and the potential transdifferentiation between bone and fat cells.
D
—
D
Peter Ebeling, MBBS, M.D., FRACP
Monash University
Beatrice Edwards, M.D., FACP
MD Anderson Cancer Center
Attending: Networking Breakfast and
Speed Networking Event
Dr. Ebeling is Head, Department of
Medicine, School of Clinical Sciences, Faculty of Medicine, Nursing
and Health Sciences, Monash University in Australia. His research includes musculoskeletal health and diseases, public health aspects of
vitamin D, post-transplantation osteoporosis, osteoporosis in men, and biochemical bone turnover markers. He currently serves on the editorial board of the
JBMR®, Osteoporosis International and Clinical Endocrinology . Dr. Ebeling serves as an ASBMR Council
Member, Medical Director of Osteoporosis Australia,
Board Member of the IOF, President of the Endocrine
Society of Australia, and Past-President of the Australian and New Zealand Bone and Mineral Society.
Dr. Edwards is Associate Professor,
Geriatric Medicine, Department of General Internal
Medicine, University of Texas, MD Anderson Cancer
Center. She is a clinician investigator and her areas of
research include the following: skeletal complications
of cancer care, breast cancer and fractures, atypical
femur fractures, ONJ, quality of life in cancer survivors, epidemiology of fractures in cancer survivors,
secondary prevention in osteoporosis, prevention of
disability in the elderly, overcoming gaps in medical
care of osteoporosis, prevention of disability: functional decline after wrist and humerus fractures, post
-marketing pharmacovigilance: osteonecrosis of the
jaw, non-healing femur fractures, acute kidney injury, esophageal cancer, and skin toxicity of novel antiresorptive agents.
Michael Econs, M.D.
Indiana University School
of Medicine
Dr. Econs is Professor of Medicine
and Medical and Molecular Genetics and Division Director of Endocrinology. His primary area of interest is the genetic aspects of metabolic bone diseases. His current
projects include clinical, genetic, and mechanistic
studies of autosomal dominant hypophosphatemic
rickets (ADHR) and autosomal dominant osteopetrosis as well as a study that focuses on the genetic determinants of bone fragility in normal individuals.
Previous efforts have led to the identification and
cloning of PHEX (X-linked hypophosphatemic rickets);
FGF23 (responsible for ADHR); ClCN7 (responsible for
autosomal dominant osteopetrosis); as well as determining that activating mutations in FGFR1 are responsible for Osteoglophonic dysplasia.
Roberta Faccio, Ph.D.
Washington University in St.
Louis School of Medicine
Event
Dr. Faccio is an Associate Professor of Orthopedics, member
of the Musculoskeletal Research Center and Adjunct
Professor of Cell Biology, Pathology and Immunology
at the Washington University School of Medicine in
St. Louis. Her research focuses on the interplay between bone and immune cells in pathological bone
loss associated with inflammatory arthritis. Dr. Faccio’s laboratory is also interested in studying the interactions between bone and immune suppressor
cells in the context of bone metastases. She has mentored several graduate students and postdoctoral fellows. Dr. Faccio lectures at local, national, and international scientific meetings and serves on the NIH
training grant study session.
E
—
F
Renny Franceschi, Ph.D.
Departments of Periodontics and
Oral Medicine, Dental School, Biological Chemistry and Biomedical
Engineering, University of Michigan
Dr. Franceschi’s laboratory studies signals regulating
the formation and functioning of osteoblasts and is
applying this knowledge to regenerate bone. Specific
projects include the understanding the role of MAP
kinase and related phosphorylation events in controlling the differentiation of mesenchymal stem cells to
osteoblasts while suppressing other lineages such as
fat; analysis of regulatory interactions between
RUNX2 and the Wnt pathway; development of gene
therapy approaches to stimulate bone regeneration
using temporally and spacially controlled expression
of BMPs and other morphogenic compounds, and
studies to elucidate the mechanism of hydroxyapatite
crystal formation in bone using Raman spectroscopy.
Deborah Galson, Ph.D.
University of Pittsburgh School of
Medicine and Cancer Institute
Dr. Galson is an Assistant Professor
at the University of Pittsburgh Cancer Institute and Department of
Medicine, Division of Hematology-Oncology. She is
interested in diseases with abnormal regulation of
osteoclastogenesis and/or osteoblastogenesis. Her
group works on two main projects: multiple myeloma regulation of the transcription repressor Gfi1 in
bone marrow stromal cells and the role of Gfi1 in the
epigenetic repression of Runx2 expression, which results in suppression of osteoblast differentiation, and
the mechanisms by which measles virus nucleoprotein alters osteoclast differentiation to generate the
aberrant osteoclasts found in Paget’s disease.
Louis Gerstenfeld, Ph.D.
Boston University School
of Medicine
Breakfast
Dr. Gerstenfeld is a Professor of Orthopedic Surgery
at Boston University School of Medicine. He has been
actively funded for 30 years and has received grants
from NIH, NASA, DOD and numerous private foundations. He has served on the Editorial Board of the
JBMR® and J. Dental Research and Bone. He has also
served on various NIH IRGs, NASA and DOD review
committees. He recently served as member of the
FDA Center for Drug Evaluation and Research Arthritis Advisory Panel and is a founding member
of ASBMR.
Julie Glowacki, Ph.D.
Brigham and Women’s Hospital
E-Mail:
[email protected]
Dr. Glowacki is Director of the
Skeletal Biology Program in the Department of Orthopedic Surgery, Brigham and Women’s Hospital. She is
Professor of Orthopedic Surgery at Harvard Medical
School and Professor of Oral & Maxillofacial Surgery
at the Harvard School of Dental Medicine. She is an
internationally recognized researcher, especially for
translation of basic research on osteoinduction to
clinical applications in plastic, oromaxillofacial, and
orthopedic uses of demineralized bone. These efforts
led to changes in clinical practice for congenital and
acquired skeletal deformities, cysts and fractures of
long bones, osseous defects in hands, and other oral
and periodontal lesions.
F
—
G
Mary Goldring, Ph.D.
Hospital for Special Surgery
and Weill Cornell Medical College in New York City
Event
Dr. Goldring is Senior Scientist
at the Hospital for Special Surgery and Professor of Cell and
Developmental Biology, Weill Cornell Medical College
in New York City. Her research on cartilage biology
focuses on the molecular regulation of extracellular
matrix remodeling. She currently serves as Associate
Editor of Journal of Cellular Physiology, Arthritis Research and Therapy, and Journal of Orthopedic Research, 2nd Vice President of the Orthopaedic Research Society (ORS) and a member of the Board of
Directors of the Osteoarthritis Research Society International (OARSI).
Steven Goldring, M.D.
Hospital for Special Surgery
and Weill Cornell Medical
College in New York City
Dr. Goldring is the Richard L. Menschel Chair and
Chief Scientific Officer at Hospital for Special Surgery
and Professor of Medicine at Weill Cornell Medical
College in New York City. His research interests focus
on the cellular and molecular mechanisms involved in
the regulation of physiological and pathological bone
remodeling. He previously served as the Chairman of
the Orthopaedics and Musculoskeletal Study Section
at NIH and has been the Chairman of the Gordon Research Conference on the Molecular Biology of Bones
and Teeth and Co-Chairman of the Keystone Conference on the Pathogenesis of Rheumatoid Arthritis.
Dr. Goldring is a Past-President and SecretaryTreasurer of ASBMR.
Ted Gross, Ph.D.
University of Washington
E-Mail:
[email protected]
Breakfast
Dr. Gross is a Professor and the
Sigvard T. Hansen, Jr. Endowed Chair in the Department of Orthopaedics and Sports Medicine at the
University of Washington. His research has consistently mixed engineering and biology, but in different
proportions over time (more recently trending toward biology). His group at UW, the Orthopaedic Science Laboratories, is a multi-faculty, multidisciplinary group with a flat organizational structure
(i.e., they dynamically form groups of varied composition for particular projects) that explores how bone
and bone cells respond to mechanical stimuli in normal and pathological situations.
Núria Guañabens, M.D.
Universitat De Barcelona, Spain
Event
Dr. Guañabens is a professor of
medicine at the University of Barcelona. Her research focus is on bone markers; liver
and bone; bone disease of organ transplantation,
particularly after liver transplantation; premenopausal osteoporosis; male osteoporosis; Paget’s disease
of bone; bone cell cultures. She is also a mother of
two children and a rheumatologist involved in practice and clinical research.
G
—
G
Marian Hannan, DSc, MPH
Harvard Medical School and the
Institute for Aging Research at
Hebrew SeniorLife
E-Mail:
[email protected]
Keith Hruska, M.D.
Washington University in St.
Louis School of Medicine
E-Mail:
[email protected]
Dr. Hruska’s laboratory changed focus from basic
Dr. Hannan is an Associate Professor of Medicine at bone cell biology to translational pathophysiology
Harvard Medical School and a Senior Scientist at the two decades ago due to the discovery that the bone
Institute for Aging Research at Hebrew SeniorLife in and mineral disorders were linked to cardiovascular
Boston, MA, USA. She is the Editor-in-Chief for the
mortality in chronic kidney disease. Their findings led
journal Arthritis Care & Research. Dr. Hannan is cur- to a new syndrome, the CKD-MBD. They have discovrently conducting research on risk factors for bone
ered the pathogenesis of the syndrome, and a new
loss, fracture, arthritis, foot disorders and osteoporo- paradigm - that renal repair mechanisms cause cardisis. She is particularly interested in the effect of bio- ovascular and skeletal disease.
mechanics upon physical function and the influence
of body composition. She has been published in over *Dr. Hruska is a Past-President of ASBMR and the
50 scientific journals, and has had continuous NIH
2014 ASBMR Shirley Hohl Service Awardee.
funding since 1996. She is also a former chair of the
ASBMR Education Committee.
Mark Horowitz, Ph.D.
Orthopaedic Histology and Histomorphometry Laboratory, Department of
Orthopaedics and Rehabilitation, Yale
Core Center for Musculoskeletal Disorders, Yale University School of
Medicine
Dr. Horowitz received his doctorate in microbiology
at the State University of New York, Upstate Medical
Center and completed his postdoctoral fellowship in
Pathology at Yale Medical School. He is Professor
and Vice Chair for Research; Director of the Orthopaedic Histology and Histomorphometry Laboratory,
Department of Orthopaedics and Rehabilitation, CoDirector, Yale Core Center for Musculoskeletal Disorders, Yale University School of Medicine. His current
research is focused on defining the interactions between the skeletal, hematopoietic and immune systems, osteoimmunology; and the origin, development and function of marrow fat. He has received
numerous awards and recognition during his career.
Carlos Isales, M.D.
University of Connecticut Health
Center School of Medicine and
New England Musculoskeletal
Institute
Breakfast
Dr. Isales trained at UPR School of Medicine and Internal Medicine at the San Juan VA Hospital. His fellowship in Endocrinology was at Yale University
School of Medicine with Dr. Howard Rasmussen. He
was initially funded by a K08 award from NIDDK. He
then moved to the Medical College of Georgia where
he is currently Professor of Orthopaedic Surgery,
Medicine and Cell Biology and Co-Director of the Institute for Regenerative and Reparative Medicine. Dr.
Isales is currently funded by the National Institutes of
Aging and his work is focused on defining the role of
nutrients in the age-dependent decline in stem cell
regenerative capacity.
H
—
I
Suzanne Jan De Beur, M.D.
Johns Hopkins University School of
Medicine, Bayview Medical Center
and Institute for Clinical and Translation Research (CTSA)
Yebin Jiang, M.D., Ph.D.
Osteoporosis and Arthritis Lab,
University of Michigan
Sophie Jamal, M.D., Ph.D.
The University of Toronto
Mark Johnson, Ph.D.
University of Missouri, Kansas
City Dental School
E-Mail:
[email protected]
Event
Dr. Jiang conducts research on
osteoporosis and arthritis. He provides quantitative and semiDr. Jan de Beur is Associate Professor of Medicine at
quantitative imaging evaluation of
the Johns Hopkins University School of Medicine, Di- osteoarthritis, rheumatoid arthritis, bone quantity
rector of the Division of Endocrinology at Johns Hop- and quality in osteoporosis including bone mineral
kins Bayview Medical Center and Associate Director measurements using DXA and QCT and bone 3D arof the Clinical Research Units of the Johns Hopkins
chitecture and geometry and bone mechanical propInstitute for Clinical and Translation Research (CTSA). erties, osteoporotic vertebral fracture assessment, in
Her clinical and research work focus on understand- epidemiological studies and in multicenter clinical
ing metabolic bone diseases at the basic level and
trials. He also conducts research in various animal
translating these observations to the bedside. Her
models of osteoarthritis, inflammatory arthritis, and
research interests include understanding the physiol- osteoporosis using various imaging modalities and
ogy of FGF23 and the molecular basis of disorders of histology.
phosphate homeostasis, the genetic basis of parathyroid hormone. Dr. Jan De Beur is current chair of the
ASBMR Professional Practice Committee.
Dr. Jamal is an Associate Professor
of Medicine at the University of Toronto and the Director of the Multidisciplinary Osteoporosis Research Program at Women’s College Hospital. She is an Endocrinologist and
Clinician Scientist who specializes in the treatment of
osteoporosis. She has a Ph.D. in Clinical Epidemiology and is the Co-Director of the Toronto Centre for
the Canadian Multicentre Osteoporosis Study. Her
major research interests include identifying novel
treatments for osteoporosis, determining the effects
of kidney disease on bone and examining the relationship between osteoporosis and vascular calcification.
Dr. Johnson received his Ph.D.
in Biochemistry from the University of Minnesota through the Mayo Clinic Graduate School of Medicine in 1980. He is currently a Professor and Chair of the Department of Oral and Craniofacial Sciences. His laboratory discovered the LRP5
G171V mutation underlying the human high bone
mass (HBM) trait and the importance of the Wnt/βcatenin signaling pathway in bone mass regulation.
He and his colleagues have recently shown that this
pathway is also critically involved in muscle-bone
crosstalk signaling and that factors produced by these
tissues can reciprocally regulate the pathway in the
other tissue. He has ongoing research involving the
mechanobiology of bone and bone-muscle crosstalk
ASBMR 2014 Annual Meeting / Houston,mechanisms.
Texas, USA / September 12-15, 2014
J
—
J
Melissa Kacena, Ph.D.
Indiana School of Medicine
Breakfast
Dr. Kacena has been an Assistant Professor of Orthopaedic
Surgery, Indiana School of Medicine since 2007. She
received her Ph.D. in Aerospace Engineering from the
University of Colorado, Boulder in collaboration with
Harvard Medical School and NASA Ames Research
Center. She completed her postdoctoral training in
the Department of Orthopaedics and Rehabilitation
at Yale University School of Medicine. While at Yale
she was promoted to Assistant Professor of Orthopaedics and Rehabilitation. Dr. Kacena’s research
focuses on the regulatory interactions between skeletal and hematopoietic cells. She has received numerous honors, young investigator awards, and grants for
her research, including NIH funding. She is also CoChair of the ASBMR Membership Engagement and
Education Committee.
David Karasik, Ph.D.
Hebrew SeniorLife and Bar Ilan
University
E-Mail:
[email protected]
Event
Dr. Karasik’s research focuses
on locating genes underlying
variation in fracture risk, including musculoskeletal,
hormonal, reproductive, and body composition traits,
by performing genome-wide association studies
(GWAS) in large human populations. This search for
genes suggested by the GWAS in humans is reinforced by a validation in animal models, based on homology between the species, followed with functional experiments. Dr. Karasik also teaches Human Anatomy to medical students and serves as Editorial
Board member or Associate Editor of JBMR®, Bone,
and BoneKEy.
Gerard Karsenty, M.D., Ph.D.
Columbia University
E-Mail:
[email protected]
Breakfast
Dr. Karsenty has spent 20
years studying all aspects of
skelelal biology from patterning to cell differentiation and
function to endocrine regulation of bone functions.
Currently, his laboratory is studying both the endocrine regulation of bone formation and the endocrine
functions of bone.
Sundeep Khosla, M.D.
Mayo Clinic College of Medicine
E-Mail:
[email protected]
Event
Dr. Khosla is the Dr. Francis
Chucker and Nathan Landow
Research Professor, Mayo Foundation Distinguished
Investigator, Director of the Center for Clinical and
Translational Science, and Dean for Clinical and
Translational Science at Mayo Clinic. Dr. Khosla’s research interests include mechanisms of age-related
bone loss and sex steroid regulation of bone metabolism. Dr. Khosla has served as Chair of the NIH SBDD
Study Section, on the Council of NIA, and as President
of ASBMR. He has received numerous awards and
honors for his work, including the Frederic C. Bartter
Award and the William F. Neuman Award
from ASBMR.
K
—
K
Douglas Kiel, M.D., MPH
Harvard Medical School, Brown
University School of Medicine
and the Institute for Aging
Research at Hebrew SeniorLife
Dr. Kiel is Professor of Medicine
at Harvard Medical School, an
Adjunct Professor of Medicine at Brown University
School of Medicine, and Director of the Musculoskeletal Research Center at the Institute for Aging Research at Hebrew SeniorLife. His research focuses on
the prevention of osteoporotic fractures and musculoskeletal decline. He is the Principal Investigator of
the Framingham Osteoporosis Study, which has identified multiple risk factors for osteoporosis and related fractures, and which has been a major contributor
to recent genome wide association studies of bone
density and other musculoskeletal phenotypes that is
now moving into next generation sequencing. Dr. Kiel
is President-Elect of ASBMR.
Lynn King, Ph.D.
National Institute of Dental and
Craniofacial Research
Event
Dr. Lynn King is the Chief of the
Research Training and Career
Development Branch, National Institute of Dental and
Craniofacial Research (NIDCR), National Institutes of
Health. Dr. King manages the NIDCR research training
portfolio, which includes individual fellowships (Fs),
career development and transition awards (Ks), institutional training grants (Ts, K12s), research supplements to promote diversity in biomedical research,
and the NIDCR Loan Repayment Program. She also
serves on the NIH training advisory committee and is
member of the NIH Common Fund working group to
implement programs aimed at enhancing diversity in
the biomedical research workforce.
Michaela Kneissel, Ph.D.
Novartis Institutes for Biomedical
Research
E-Mail:
[email protected]
Event
Dr. Kneissel is Global Head of the
Musculoskeletal Disease Area (MSD) at the Novartis
Institutes for BioMedical Research. MSD pursues the
identification of therapies for muscle wasting and
weakness, neuromuscular diseases, debilitating bone
and mineral metabolism disorders as well as for tendon and joint repair. Dr. Kneissel received her Ph.D.
from the University of Vienna, Austria. She performed part of her Ph.D. work at the Hard Tissue Research Unit, University College London, UK and was
postdoctoral fellow at the Radiobiology Division, University of Utah, Salt Lake City, USA before joining Novartis in 1996 where she has held several positions of
increasing responsibility. In recent years some of her
research interest was focused on the bone formation
inhibitor sclerostin and osteocyte biology.
Stavroula Kousteni, Ph.D.
Columbia University
Dr. Kousteni is an Associate Professor of Medicine and Physiology
and Cellular Biophysics at Columbia University. Her
research interests focus on the transcriptional control
of bone loss with emphasis on: interactions among
pathways that regulate oxidative stress, longevity and
skeletal homeostasis; Interorgan control of skeletal
and glucose metabolism by exploring the novel endocrine function of bone as a regulator of energy homeostasis. To address these research interests her laboratory uses molecular and cellular biology and
mouse genetics. She has served on the ASBMR Scientific Program Committee and Publications Committee
and is currently Co-Chair of the ASBMR Membership
Engagement and Education Committee.
K
—
K
Christopher Kovacs, M.D.
Memorial University of Newfoundland
Event
Henry Kronenberg, M.D.
Massachusetts General Hospital
Barbara Kream, Ph.D.
Center
Nancy Lane, M.D.
Davis Medical Center
E-Mail:
[email protected]
Dr. Kronenberg is Chief of the Endocrine Unit at the Massachusetts GenDr. Kovacs is a Professor of
eral Hospital and Professor of MediMedicine (Endocrinology), Ob- cine at the Harvard Medical School. There he leads a
stetrics/Gynecology, and Bioresearch group that studies the actions of parathyMedical Sciences at Memorial roid hormone and parathyroid hormone-related proUniversity of Newfoundland. His clinical practice fo- tein, largely through the use of genetically manipulatcuses on osteoporosis and endocrinology while his
ed mice. Dr. Kronenberg received his BA from Harbasic research examines calcium and bone metabo- vard University, his M.D. from Columbia University,
lism during the reproductive periods (pregnancy, lac- his medical house officer training at the Massachutation, and fetal development). He received the Gold setts General Hospital, and post-doctoral training at
Medal in Medicine from the Royal College of PhysiNIH, MIT, and the MGH.
cians and Surgeons of Canada and Young Investigator
Awards from ASBMR, AIMM, and CSEM. He serves on
Editorial Boards of JBMR® and Endocrinology, and on
CIHR and NIH grant committees. He was also on the
Institute of Medicine Committee to Review Calcium
and Vitamin D.
Dr. Kream is Professor of Medicine at the University of Connecticut Health Center in Farmington,
Connecticut. She graduated from Mount Holyoke College (BA, Chemistry) and Yale University (Ph.D., Molecular Biophysics and Biochemistry) and did postdoctoral work at the University of Wisconsin Health Center. Her research interests include the roles of local
and systemic hormones in bone remodeling using
transgenic mouse models. She has served as Director
of the M.D./Ph.D. program and now holds the position of Associate Dean of the Graduate School. Dr.
Kream is a Past-President of ASBMR.
Dr. Lane is a rheumatologist with
an expertise in osteoporosis and bone biology.
Throughout her career she has performed novel clinical studies involving the use of PTH for the treatment
of glucocorticoid induced osteoporosis and currently
designing studies with a compound to direct mesenchymal stem cells to the bone surface to form bone.
Dr. Lane has experienced organizing a research team
and also has a small clinical practice.
K
—
L
Thomas Lang, Ph.D.
University of California, San
Francisco
E-Mail:
[email protected]
Dr. Lang is Professor of Radiology and Biomedical Imaging at UC San Francisco, focusing on clinical imaging related to osteoporosis and sarcopenia. His primary research interests are the application of noninvasive imaging, in particular CT, to study the morphological and functional alterations of the musculoskeletal system related to osteoporosis and sarcopenia. His laboratory has developed widely used methods to analyze musculoskeletal images and have accumulated considerable experience in applying these
methods to solve important biomedical problems.
The group pioneered the development and application of vQCT and have recently adapted neuroimaging methods to analyze detailed proximal femoral
structure in relation to age, fracture risk and drug
treatment.
Bente Langdahl, M.D., DMSc
Aarhus University Hospital
Dr. Langdahl graduated from medical school at Aarhus University in
1988. She is a consultant at the Department of Endocrinology at Aarhus University Hospital and a professor and research lecturer at Aarhus University. Dr.
Langdahl received her Ph.D. at Aarhus University in
1995 with a focus on investigations on a possible
pathogenic role of thyroid hormones in postmenopausal osteoporosis and received a DMSc at the same
university on the genetics of bone mass and risk of
osteoporotic fractures. Dr. Langdahl’s main research
interests are genetics of osteoporosis, osteogenesis
imperfecta, interactions between fat and bone, diabetes and bone, vitamin D and K, new treatments for
osteoporosis. She is Past-President of the European
Calcified Tissue Society.
Beate Lanske, Ph.D.
Harvard School of Dental Medicine,
E-Mail:
[email protected]
Dr. Lanske’s laboratory is located at the Harvard
School of Dental Medicine in Boston, USA. A key interest of her lab has been, and continues to be, FGF23, a circulating phosphaturic factor produced in osteoblasts and osteocytes. Their research interest is
mainly focused on the endocrine regulation of mineral ion homeostasis by FGF23/Klotho signaling, renal
failure and the consequences on bone mineralization,
and on the induction of secondary hyperparathyroidism. They are using a wide variety of animal models
and molecular biology techniques to investigate
those topics.
Meryl Leboff, M.D.
Brigham and Women's Hospital,
Event
Dr. LeBoff is an endocrinologist
and director of the Skeletal Health
and Osteoporosis Center and Bone Density Unit and
Chief of the Calcium and Bone Section at Brigham and
Women’s Hospital (BWH). She is a Professor of Medicine at Harvard Medical School and the BWH, Distinguished Chair in Skeletal Health and Osteoporosis.
Dr. LeBoff previously served as a Councilor for ASBMR
and represents the ASBMR on task forces related to
fracture care and bone density and body composition
measures. Her current research focuses on the
effects of vitamin D on fractures and bone health outcomes in the VITamin D and OmegA-3 Fatty Acid TriaL
(VITAL), and optimization of musculoskeletal health
across the life span.
L
—
L
Brendan Lee, M.D., Ph.D.
Baylor College of Medicine
Breakfast
Yanfei Linda Ma, M.D.
Eli Lilly and Company
Dr. Ma is a Research Fellow in the
Dr. Lee is the Robert and
Musculoskeletal Research Team at
Janice McNair Endowed Chair
Eli Lilly and Company. Before joinin Molecular and Human Genetics, Professor and in- ing Lilly in 1998, she was a postdoctoral fellow, and
terim Chairman of the Department of Molecular and then assistant research professor at the University of
Human Genetics at Baylor College of Medicine. Dr.
Utah. Dr. Ma’s main research interest is Osteoporosis
Lee co-directs the joint MD Anderson Cancer Center and other musculoskeletal related disorders such as
and Baylor College of Medicine Rolanette and Berdon orthopedic bone healing, muscle wasting with focus
Lawrence Bone Disease Program of Texas, and the
on skeletal pharmacology effects of PTH, SERMs,
Baylor College of Medicine Center for Skeletal Medi- Prostaglandins, VDRMs, SARMs and Wnt pathway in
cine and Biology. He studies human and mouse gethe related areas.
netic models of skeletal dysplasias to elucidate mechanisms that specify skeletal homeostasis and drive
cancer.
Joseph Lorenzo, M.D.
Center
Event
Stavros Manolagas, M.D.,
Ph.D.
University of Arkansas for Medical Sciences (UAMS)/VA Center
for Osteoporosis and Metabolic
Bone Diseases
Breakfast
Dr. Lorenzo has over 30 years
experience in bone biology research with a particular interest
in osteoimmunology and osteoporosis. He currently serves as ASBMR’s Scientific
Dr. Manolagas is a Distinguished Professor of MediWeb Editor and writes a monthly blog, which can be cine, the Andreoli Clinical Scholar Chair, and the Difound on the ASBMR website.
rector of the Division of Endocrinology and Metabolism and the University of Arkansas for Medical Sciences (UAMS)/VA Center for Osteoporosis and Metabolic Bone Diseases. His research interests include
the cellular and molecular mechanisms of osteoporosis, steroid hormone receptor action, osteoblast and
osteocyte biology, and apoptosis. He is the author of
over 200 original articles and the recipient of the Louis V. Avioli Award from ASBMR and the D. Harold
Copp Award from IBMS for outstanding achievements in basic research.
L
—
M
Toshio Matsumoto, M.D.
University of Tokushima Graduate School of Medical Sciences
E-Mail:
[email protected]
Breakfast
Dr. Matsumoto graduated from
the University of Tokyo in 1974. He is Director of the
Fujii Memorial Institute of Medical Research, University of Tokushima. He has served as a Councilor of the
ASBMR (2000-2002), as Board member of the IBMS
(1995-2005) as the JSBMR President (2006-2009). He
currently serves as the Presdient of the Japan Endocrine Society, as a member of Committee for Scientific Advisors of the IOF and as an Advisory Committee member of the CABS. He is an Associate Editor
for BoneKEy and JBMM, and an Editorial Board member for Endocrinology, Osteoporosis International,
Current Osteoporosis Report and Journal of Bone Oncology.
Laura McCabe, Ph.D.
Michigan State University
E-Mail:
[email protected]
Dr. McCabe obtained her
BS and Ph.D. from the
University of Chicago. Her graduate research focused
on diabetes-induced changes in the intestine, with
specific emphasis on altered intestinal enterocyte
differentiation. During her post-doc in Dr. Gary
Stein’s lab she studied molecular regulators of osteoblast differentiation. In 1996, she moved to Michigan
State University (with her husband and two sons) and
joined the Department of Physiology faculty and began studying effects of diabetes/metabolism on osteoblast differentiation/function. Currently, she is the
Associate Chair of Physiology and her laboratory is
focused on gut signaling pathways that regulate bone
density under disease states.
Laurie McCauley, D.D.S.,
Ph.D.
University of Michigan
School of Dentistry
E-Mail:
[email protected]
Breakfast and Speed
Networking Event
Dr. McCauley was recently appointed Dean of the
School of Dentistry at the University of Michigan, and
is also the William K. and Mary Anne Najjar Professor,
Department of Periodontics and Oral Medicine,
School of Dentistry, and Professor, Department of
Pathology, Medical School, University of Michigan.
Dr. McCauley’s research interests include: hormonal
controls of bone remodeling, anabolic actions of parathyroid hormone (PTH) and PTH-related protein
(PTHrP) with a focus on their cellular mechanisms of
action, the role of PTHrP in skeletal metastasis, the
impact of therapeutics for bone disease on oral bone
healing, and experimental models of metabolic bone
disease, skeletal metastasis and bone regeneration.
Joan McGowan, Ph.D.
National Institute of Arthritis,
Musculoskeletal and Skin
Disease (NIAMS)
Event
Dr. McGowan is the Director of the Division of Musculoskeletal Diseases at the National Institute of Arthritis and Musculoskeletal and Skin Diseases. Before
joining NIH, She was a faculty member at the Harvard
Medical School. Dr. McGowan has been very active
in osteoporosis and women's health activities at NIH.
She served as the Senior Scientific Editor of the Surgeon General’s Report on Osteoporosis and Bone
Health published in 2004. Dr. McGowan also serves
as the NIH Liaison to the Bone and Joint Decade Initiative and the National Bone Health Alliance.
M
—
M
Robert McLean, DSc
Hebrew SeniorLife Institute
for Aging Research and
E-Mail:
[email protected]
Robert Nissenson, Ph.D.
VA Medical Center and University of California, San Francisco
E-Mail:
[email protected]
Breakfast
Dr. McLean is an epidemiologist in the Musculoskeletal Research group at the Hebrew SeniorLife Institute
for Aging Research and Harvard Medical School in
Boston. His research focuses on risk factors for agerelated declines in muscle and bone, as well as their
roles in the risk for falls and related fractures in older
adults. Dr. McLean teaches the clinical epidemiology
at Harvard Medical School, and he regularly leads
workshops at national scientific meetings on evidence-based medicine, critical appraisal of research
proposals, grant writing and epidemiologic methods.
Dr. Nissenson is a basic scientist with interests in bone biology and cell signaling.
His training is in the area of G protein-coupled receptor signaling. After earning a Ph.D. in Biology at
Northwestern University, he moved to the Mayo Clinic where he developed an interest in bone biology
and PTH action. After moving to the UCSF-affiliated
VA Medical Center in 1977, he continued to study
molecular aspects of PTH receptor signaling as well as
PTH-related protein. His recent focus has been on
the use of mouse models to unravel the links between G protein signaling in osteoblasts and bone
formation in vivo.
Salvatore Minisola, M.D.
“Sapienza” University of
Rome
Breakfast
Deb Novack, M.D., Ph.D.
Washington University in
St. Louis School of Medicine
E-Mail:
[email protected]
Attending: Speed
Networking Event
Dr. Minisola is Full Professor
of Internal Medicine, Department of Internal Medicine and Medical Disciplines. His research focuses on
the clinical investigation of metabolic bone diseases,
most notably osteoporosis and primary hyperparathyroidism. He is Past- President of the Italian Society
of Osteoporosis, Mineral Metabolism and Skeletal
Diseases (SIOMMMS) and is a member of ASBMR, the
Italian Society of Internal Medicine and the European
Society of Calcified Tissues. He also serves on the Editorial Board for many journals and has authored and
co-authored more than 165 articles in international
peer-reviewed Journals and written several review
and book chapters.
Dr. Novack is an Associate Professor of Medicine and
Pathology in the Division of Bone and Mineral Diseases at Washington University. Her research focuses on
pathological bone loss, particularly in the context of
inflammatory arthritis and bone metastasis. In addition to running a lab, she has an active practice in surgical pathology, specializing in metabolic bone disease and breast cancer. She is married with 2 teenage sons and 2 dogs. She is an ASBMR Councilor.
M
—
N
Eric Orwoll, M.D.
Oregon Health and Science
University
Merry Jo Oursler, Ph.D.
Mayo Clinic
E-Mail:
[email protected]
Dr. Orwoll’s research interest is in the elucidation of
pathophysiological mechanisms of metabolic bone
disease and the discovery of new therapeutic and diagnostic tools for the clinical care of patients with
osteoporosis. His major areas of investigation have
been in the area of osteoporosis in men, and the role
of sex steroids in the regulation of bone metabolism.
He is the PI of several research studies funded by
NIH, including the Study of Osteoporotic Fractures in
Men (MrOS), and has authored over 300 peer reviewed publications, reviews, books and book chapters. He is a past ASBMR Councilor.
Dr. Oursler is a Professor of
Medicine in the Endocrine
Research Unit at the Mayo
Clinic. She received her Ph.D. from Washington University in St. Louis and her postdoctoral training was
at the Mayo Clinic. Additionally, she worked as Associate Professor in the Biology Department at the University of Duluth. Dr. Oursler has served on the ASBMR Education Committee and as Chair from 2007 to
2010. She represented ASBMR on the FASEB Training
and Career Opportunities Subcommittee from 20072012. Her research interest is the cell biology of osteoclasts. Her hobbies include gardening, painting, and
figure skating.
Susan Ott, M.D.
University of Washington
Medical Center
Breakfast
Dr. Ott started her career in
nephrology and became involved in renal osteodystrophy, osteoporosis, bone density, and bone histomorphometry. She has been an
investigator in clinical trials of osteoporosis therapies,
and is currently studying atypical femur fractures related to bisphosphonates. Colleagues have called her
a cassandra and an iconoclast for her views about
bisphosphonates. She is a co-investigator in a series
of studies of the skeletal effects of pregnancy and
contraception. She served on the KDIGO guidelines
committee about mineral and bone disorders. Her
main claim to fame is her web page about osteoporosis and bone physiology, which can be found here.
Babatunde Oyajobi,
MBBS, Ph.D.
University of Texas
Health Science Center at
San Antonio
E-Mail:
[email protected]
Breakfast
Dr. Oyajobi is a tenured
Associate Professor in
the department of Cellular & Structural Biology at the
University of Texas Health Science Center at San Antonio. His research interests are cancer-induced bone
diseases and multiple myeloma bone disease specifically. He is particularly interested in preclinical development of new therapeutics for myeloma.
O
—
O
Roberto Pacifici, M.D.
Emory University
E-Mail:
[email protected]
Breakfast
Dr. Pacifici is the Garland
Herndon Professor of Medicine and Director of the
Division of Endocrinology, Metabolism and Lipids at
Emory University. He is an expert on the mechanism
of action of sex-steroids and PTH in bone and one of
the founders of the field of osteoimmunology. He
has been the first to demonstrate a role for T lymphocytes in the regulation of bone metabolism in
health and disease. He is also an expert on bone densitometry and the clinical management of osteoporosis. He has published 83 papers and 40 chapters and
serves as the PI in 3 NIH grants and 1 DOD grant.
Alexandra Papaioannou, BScN,
M.D., MSc, FRCP(C), FACP
Hamilton Health Sciences
Event
Dr. Papaioannou is a Professor in
the Department of Medicine and
a Geriatrician at Hamilton Health
Sciences. She serves as the Scientific Director of the
Geriatric Education and Research in Aging Sciences
(GERAS) Centre and holds a Canadian Institute of
Health and Research – Eli Lilly Research Chair. She is
also an Associate Member in the Department of Clinical Epidemiology and Biostatistics and Medical Sciences, a member of the Scientific Advisors of Osteoporosis Canada and the International Osteoporosis
Foundation and was the lead author, Osteoporosis
Canada Guidelines published in Canadian Medical
Association Journal (CMAJ) October 2010. She is the
project lead for the Ontario Osteoporosis Strategy for
Fracture Prevention in Long-term Care, Co-Director of
the Hamilton Canadian Multi-Centre Osteoporosis
Study (CaMos) and is leading the Fracture Think
Osteoporosis project.
Nicola Partridge, Ph.D.
New York University College
of Dentistry
Dr. Partridge has been Professor and Chair of Basic Science and Craniofacial Biology at New York University
College of Dentistry since September, 2009. She received her Ph.D. from the University of Western Australia and then undertook postdoctoral training at the
University of Melbourne and Washington University,
St. Louis. Subsequently, she was tenure-track faculty
rising to tenured Professor at Saint Louis University.
In 2000, she was recruited as Professor and Chair of
Physiology and Biophysics at UMDNJ-Robert Wood
Johnson Medical School. Her research focuses on PTH
regulation of gene expression.
Carol Pilbeam, M.D.,
Ph.D.
University of Connecticut Health Center
E-Mail:
[email protected]
Dr. Pilbeam considers
medicine her second
career, following a brief stint as a geophysicist. Her
research focus is cyclooxygenase-3 and prostaglandins in bone-- regulation by factors important to
bone turnover, such as mechanical loading and PTH,
and role in bone physiology and pathology. Her medical training was in geriatrics, with a specialty in osteoporosis. One of her biggest joys over the years has
been working with students at all levels, from summer interns to graduate students to junior faculty.
Dr. Pilbeam considers herself fortunate to be taking
on a new type of mentoring as director of the UCONN
M.D.-Ph.D. program.
P
—
P
Lilian Plotkin, Ph.D.
Indiana University School of Medicine
Dr. Plotkin is an Associate Professor at the Department of Anatomy and Cell Biology, Indiana University School of
Medicine. She obtained her degree in Immunology at
the University of Buenos Aires in Argentina and performed postdoctoral training at the Endocrinology
Division and the Center for Osteoporosis and Metabolic Bone Diseases, University of Arkansas for Medical Sciences. Dr. Plotkin’s research focuses on the
role of connexin43 as a regulator of intracellular signaling in bone. Her work has been published in JCI,
JBC, AJP, JBMR® and Bone. Dr. Plotkin’s research has
been supported by local grants, and the NOF and the
NIH.
Joanna Price, D.V.M., Ph.D.
University of Bristol School
of Veterinary Sciences and
Royal Veterinary College
E-Mail:
[email protected]
Breakfast and Speed
Networking Event
Dr. Price qualified as a veterinarian, spent time in
clinical practice then studied for a Ph.D. on antler regeneration. She also worked as a post-doctoral fellow
on functional adaptation in bone and has worked on
bone regeneration. Her research focuses on functional adaptation in bone, in particular interactions between the oestrogen receptor and other signalling
pathways and the effect of ageing on the mechanostat as well as the pathogenesis and prevention of
musculoskeletal injuries in horses. She currently
serves as Professor of Veterinary Anatomy and Department Chair at the Royal Veterinary College and
Head of Bristol Veterinary School.
Robert Recker, M.D.
Creighton University
Dr. Recker, a 1963 graduate of
the Creighton University School
of Medicine, and Director of the
Creighton University Osteoporosis Research Center,
is an internationally recognized expert in the field of
osteoporosis and metabolic bone disease. His 40-plus
year career as physician-scientist includes laboratory
and clinical research, teaching, patient care, and professional leadership. He holds the ranks of Master,
American College of Physicians, and Fellow, American
College of Endocrinology. He is Past President of both
the National Osteoporosis Foundation and the American Society for Bone and Mineral Research. His list of
professional publications includes more than 450
original papers, chapters, and monographs.
Yumie Rhee, M.D., Ph.D.
Yonsei University College
of Medicine
Event
Dr. Rhee is an Associate Professor
of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea. She studied
parathyroid hormone with Dr. Sung-Kil Lim then PTH
led her to the field of the osteocytes. She worked
with Dr. Teresita Bellido at Indiana University School
of Medicine from 2008 to 2010. Dr. Rhee also worked
through genetically engineered mouse models that
had osteocyte-driven bone remodeling. Back home in
Seoul, Korea, she is currently involved in studying rare skeletal diseases and pregnancy/lactationassociated bone metabolism. Her research focus is on
osteocyte biology, disorders of calcium and phosphate metabolism and rare skeletal diseases.
P
—
R
Pamela Robey, Ph.D.
Ann Schwartz, Ph.D.
San Francisco
Dr. Robey is chief of the Craniofacial and Skeletal Diseases
Branch of the National Institute
of Dental and Craniofacial Research, co-coordinator
of the Bone Marrow Stromal Cell Transplantation
Center, and Acting Scientific Director of the Stem Cell
Unit at NIH, DHHS. She is currently the Deputy Editor
-in-Chief of Stem Cell Research, and on the editorial
board of JBMR® and Stem Cells. Dr. Robey and her
coworkers focus on developing insight into the biological activities of skeletal stem cells, the role that
they play in disease, and how they can be utilized in
tissue engineering and regenerative medicine.
Dr. Schwartz is Professor of Epidemiology and Biostatistics at
University of California San Francisco. She is an internationally recognized expert on the epidemiology of
fractures, osteoporosis and falls in older adults with
diabetes. She has published on the increased risk of
fractures and falls in type 2 diabetes, the limitations
of standard tools in assessing fracture risk in this population, and the negative effects of thiazolidinediones
on skeletal health. Dr. Schwartz chairs the program
committee for the 2014 ASBMR Symposium: The
Effects of Diabetes and Disordered Energy Metabolism on Skeletal Health.
Kenneth Saag, M.D., MSc
University of Alabama (UAB) and
UAB School of Public Health
Ego Seeman, M.D., FRACP
Austin Health, University of
Melbourne
Dr. Saag is the Jane Knight Lowe
Professor of Medicine, Division
Dr. Seeman’s research interof Clinical Immunology/
ests include growth and decay
Rheumatology at the University of Alabama at Birof the microstructure of the skeleton as they relate to
mingham (UAB), and Professor of Epidemiology, at
bone fragility. He is also interested in the challenges
UAB School of Public Health. He is the founding Diin noninvasive imaging of bone
rector of the Deep South Musculoskeletal (DSM) Center for Education and Research on Therapeutics
(CERTs) and Director of the AHRQ-supported UAB T32
in Health Services Research. Dr. Saag is also Director
of the UAB Center for Outcomes and Effectiveness
Research (COERE), a university-wide supported interdisciplinary research center and Associate Director of
the Multidisciplinary Clinical Research Center (NIAMS
P60).
R
—
S
Elizabeth Shane, M.D.
Columbia University, College of
Physicians and Surgeons in New
York City
Dr. Shane is Professor of Medicine, Vice Chair of
Medicine for Clinical and Epidemiological Research at
Columbia University, College of Physicians & Surgeons in New York City. Her research interests include transplantation osteoporosis, premenopausal
osteoporosis, bone disease associated with HIV/AIDS,
renal bone disease, bone loss due to medications and
gastrointestinal diseases, and the use of high resolution imaging to investigate the effects of various
drugs and diseases on bone quality and strength. She
currently serves on the Advisory Council for the
National Institute of Arthritis, Musculoskeletal and
Skin Diseases. She is also Past-President of ASBMR
and has served on the Editorial Board for the JBMR®.
William Sharrock, Ph.D.
National Institute of Arthritis
and Musculoskeletal and Skin
Diseases
Breakfast
Eileen Shore, Ph.D.
Perelman School of Medicine
at the University of Pennsylvania and Center for FOP
and Related Disorders
E-Mail:
[email protected]
Dr. Shore is the Cali and Weldon Professor in FOP at
the Perelman School of Medicine at the University of
Pennsylvania in the Departments of Orthopaedic Surgery and Genetics, and is the Co-Director of the Center for Research in FOP and Related Disorders. She
uses molecular/cell biology and genetics approaches
to investigate differentiation and development in human genetic disease, focusing on two rare disorders
of de novo formation of extra-skeletal bone. She is a
past-President of the Advances in Mineral Metabolism (AIMM) Board of Directors and
Lillian Shum, Ph.D.
Dr. Shum is Acting Director of
Dr. Sharrock is Program Director
the Division of Extramural Refor Integrated Physiology and
search at the National Institute
Genetics of Bone in the Division of Musculoskeletal
of Dental and Craniofacial Research (NIDCR), NIH.
Diseases at the NIAMS. His portfolio includes topics
She provides leadership and guidance for the plansuch as interactions and communication between
ning, development, implementation and evaluation
bones and other tissues and organ systems, response of NIDCR extramural research portfolio encompassing
of bone to mechanical loading and unloading, and
diverse areas in dental, oral and craniofacial sciences.
genetic influences on skeletal traits. In addition, he
Relevant to mineralized tissue-related research,
tracks and coordinates trans-NIH efforts in genetics
NIDCR provides funding for dental and craniofacial
and genomics for the NIAMS, participating in such as skeletal biology, development, diseases, disorders,
the Genes and Environment Initiative and the Comrepair, regeneration, and biomaterials. Dr. Shum
mon Fund Epigenomics Program.
earned her doctoral degree in cell and developmental
biology from UNC-Chapel Hill and completed postdoctoral training at USC and UCSF studying growth
and transcription factor signaling.
S
—
S
Natalie Sims, Ph.D.
St. Vincent’s Institute, Melbourne
Dr. Sims is Associate Director and
Professor at St. Vincent’s Institute. She directs the Bone Cell
Biology and Disease Unit at St.
Vincent’s Institute and is a Principal Research Fellow at The University of Melbourne.
Her work focuses on paracrine control of osteoblast
and osteoclast function, particularly ephrin and IL-6
family cytokines, using genetically altered mouse
models and in vitro systems. Dr. Sims is a board
member of the Australian and New Zealand Bone and
Mineral Society, IBMS, ASBMR (Fuller Albright Award
winner), and is a Senior Editor of the journal Bone,
and past Associate Editor of CTI.
Paula Stern, Ph.D.
Northwestern University Feinberg School of Medicine
Email:
[email protected]
Event
Dr. Stern is a Professor and
Vice-Chair of the Department
of Molecular Pharmacology and Biological Chemistry
at the Northwestern University Feinberg School of
Medicine. She received her Ph.D. in Pharmacology
from the University of Michigan, and did postdoctoral
work at the University of Rochester. Dr. Stern’s research interests are in the area of bone cell biology,
focusing on signal transduction in response to hormones and cytokines. Her recent studies have addressed G12/G13 – Rho A – phospholipase D signaling in osteoblasts and NFAT signaling in osteoclasts.
Dr. Stern was the sixth ASBMR President and currently represents ASBMR on the Breakthroughs in Bioscience Committee of FASEB.
Larry Suva, Ph.D.
University of Arkansas for Medical Sciences
Event
Dr. Suva is a native of Australia,
with more than 30 years of research experience focused on
the skeletal consequences of disease. He is a professor in the Departments of Orthopaedic Surgery and
founding Director of The Centre for Orthopaedic Research at the University of Arkansas for Medical Sciences. He is the author of more than 130 peerreviewed scientific publications and five released patents describing the skeletal complications of disease.
He is an active member of AAOS, ORS, IBMS, and ASBMR. His research interests include the pathogenesis
of multiple myeloma and breast cancer progression,
effects of chemotherapeutic agents on bone, fracture
repair as well as distraction osteogenesis, osteomyelitis and the regulation of bone formation.
Pawel Szulc, M.D., Ph.D.
INSERM UMR 1033, University of Lyon, Hopital E.
Herriot, Pavillon F
E-Mail:
[email protected]
Dr. Szulc graduated from
the Medical Faculty in Warsaw. He previously worked as a clinical and research
assistant in the Dept. of Endocrinology, Medical Center for Postgraduate Education, Warsaw, Poland and
as a part of the INSERM Research Unit in Lyon,
France. Currently, Dr. Szulc is a research worker in
the INSERM UMR 1033 in Lyon, France (civil servant
of INSERM). His fields of scientific interest include osteoporosis in men, biochemical markers of bone turnover, relationship between muscle mass and bone
morphology, relationship between osteoporosis and
cardiovascular diseases, and vertebral fractures.
S
—
S
Sakae Tanaka, M.D., Ph.D.
The University of Tokyo
E-Mail:
[email protected]
Breakfast
Dr. Tanaka works in the Department of Orthopaedic
Surgery, Faculty of Medicine, The University of Tokyo. His clinical specialty is rheumatology and joint
surgery. He is also interested in the molecular mechanisms of osteoclast differentiation and activation. He
is currently working on the epigenetic regulation of
RANKL-induced osteoclast differentiation.
Steven Teitelbaum, M.D.
Washington University in
St. Louis School
of Medicine
Breakfast
Dr. Teitelbaum is the Wilma and Roswell Messing
Professor of Medicine, Pathology and Immunology at Washington University
School of Medicine. His research focuses on the osteoclast and its role in the pathogenesis of metabolic
diseases of bone. He has published in excess of 300
scientific papers and received many prestigious
awards. His greatest accomplishment, however, is his
trainees, many of whom hold distinguished positions
throughout the world. Dr. Teitelbaum is Past President of FASEB and ASBMR.
Anna Maria Teti, Ph.D.
University of L’Aquila, Italy
Event
Dr. Teti is Professor of Histology at the University of L'Aquila,
Italy. Her professional interests
are bone cell biology and pathology, osteoporosis,
cancer induced bone diseases, and osteopetrosis. Dr.
Teti has served on committees for the European Symposia on Calcified Tissues, Austrian Society for Bone
and Mineral Research, European Calcified Tissues Society, IBMS, and ASBMR. She has served on the Editorial Board for BONE, Calcified Tissue International,
Endocrinology, Archives of Biochemistry and Biophysics, BoneKey, and British Journal of Pharmacology.
She has 158 peer-review article in international journals.
Dwight Towler, M.D., Ph.D.
Sanford-Burnham Medical Research Institute
E-Mail:
[email protected]
Event
Dr. Towler is Director of Cardiovascular Pathobiology
at Sanford-Burnham Medical Research Institute, and
Sr Investigator, Florida Hospital Translational Research Institute. Prior to moving to Orlando, he was
the Lang Professor of Medicine, Barnes-Jewish Hospital at Washington University Medical Center, and
served for 10 years as Chief of the Division of Bone
and Mineral Diseases. In Type 2 Diabetes, arteriosclerotic calcification is a powerful contributor to the
risk for lower extremity fracture, fracture non-union,
and foot amputation. Dr. Towler’s research emphasizes the endocrine regulation of arteriosclerotic calcification and bone-vascular interactions in the
setting of Type 2 Diabetes.
T
—
T
Johannes Van Leeuwen, Ph.D.
Erasmus University Medical Center
E-Mail:
[email protected]
Dr. van Leeuwen studied biology in Amsterdam, and
did his Ph.D. study on the mechanism of action of
PTH in Leiden, The Netherlands. Currently he is professor of Calcium and Bone Metabolism and Head of
the Laboratory Internal Medicine of the Erasmus University Medical Center, Rotterdam, The Netherlands.
Research focus is on regenerative medicine with emphasis control of mesenchymal stem cell and osteoblast differentiation, the impact of bone metabolism
on hematopoietic stem cell control and tumor cell
metastasis, and on calcium, phosphate and bone metabolism and healthy aging. He is founder of the biotech company Arcarios BV.
Jason Wan, Ph.D.
Craniofacial Research (NIDCR)
Dr. Wan is Director of the Mineralized Tissue Physiology Program
at the National Institute of Dental
and Craniofacial Research (NIDCR). This portfolio covers many craniofacial bone and tooth projects ranging from basic to translational. Prior to joining NIDCR,
Dr. Wan was with the National Institute of Diabetes
and Digestive and Kidney Diseases. He obtained his
doctoral degree in Biochemistry and Molecular Biophysics at the University of Pennsylvania and has conducted research on metalloenzymes and proteins involved in inflammatory pathways. Outside of work,
he enjoys playing tennis.
Jennifer Westendorf, Ph.D.
Mayo Clinic in Rochester, Minnesota
E-Mail:
[email protected]
Event
Dr. Westendorf is a Professor of
Orthopedics, Biochemistry and Molecular Biology
(BMB) at Mayo Clinic in Rochester, Minnesota. Her
research interests are the transcriptional mechanisms
regulating osteoblast differentiation and function.
The major focus of her NIH-supported research program is in understanding how Wnt signaling components, Runx factors, and histone deacetylases (Hdacs)
regulate gene expression, cell differentiation, bone
formation and tumorigenesis though epigenetic and
other molecular mechanisms. She is also interested
in regenerative medicine for orthopedic applications.
She recently completed terms on the ASBMR Council
and as chair of the NIAMS AMS study section.
Bart Williams, Ph.D.
Van Andel Research Institute
Dr. Williams received his Ph.D.
in biology from Massachusetts
Institute of Technology under
the supervision of Tyler Jacks. Subsequently, he was a
post-doctoral fellow at the National Institutes of
Health in the laboratory of Harold Varmus. He started
his own laboratory at the Van Andel Research Institute in Grand Rapids, Michigan in 1999 where he has
focused on examining the role of the Wnt signaling
pathway in development and disease. His laboratory
has placed a particular emphasis on generating and
characterizing genetically engineered mouse models
to address the role of Wnt signaling in osteoblast
differentiation, osteoporosis, and skeletal metastasis.
V
—
W
John Williams, Ph.D.
National Institutes on Aging
(NIA)
E-Mail:
[email protected]
Event
Dr. Williams has been in the “bone field” since 1993
and did research primarily on osteoclasts until the
end of 2007. He became the Director of the Musculoskeletal Biology Program in the Division of Aging
Biology (DAB) at the National Institute on Aging in
January 2008. DAB is one of the four divisions at NIA,
and is the basic science division for non-brain research at the National Institute on Aging. Most areas
of research relevant to ASBMR members have a significant “Aging” component, whether it is basic or
clinical sciences.
Joy Wu, M.D., Ph.D.
Stanford University School of
Medicine
Dr. Wu is a physician scientist at
Stanford, with a clinical practice
in osteoporosis and metabolic
bone disease. Her research lab
studies osteoblast differentiation and the bone marrow hematopoietic niche.
W
—
W

Speed Networking and Networking Breakfast Mentor Guide

Transcription

Similar documents

Layzie, Krayzie, Bizzy

Performance Groups

On Track April 2016

New England`s leading provider of benefits education

newsletter - Healthwaves

Software developments in CT scanning

Desinewer Deboner

healthy me news - Carnegie Mellon University

Maturation of Erythrocytes - Fall River Public Schools